Featured Item: Show on home page
November 17, 2025
Members of the Pan-Canadian Cancer Genomics Community of Practice contributed to the development of a consensus-based assessment framework to support the standardized, efficient, and transparent evaluation of molecular, genetic, and genomic biomarkers in cancer care in Canada.
…
The pan-Canadian Quality Assurance in Radiopharmaceutical Therapy (pCQRT) advisory committee — one of CAPCA’s standing committees — recently met to set its upcoming priorities.
This marks the committee’s first multi-year work plan and outlines how pCQRT will help support safe,…
As the organization that brings together the leadership of all provincial cancer agencies and programs, the Canadian Association of Provincial Cancer Agencies with support from the Canadian Cancer Society has collaborated with member and partner organizations to assess cancer workforce…
Join the Pan-Canadian Cancer Data Strategy: Pan-Canadian RT Data Harmonization Project Webinar. There are two sessions to choose from.
The goal of this document is to standardize eligibility criteria for CAR T-cell therapy across Canada.
The Pan-Canadian Cancer Genomics Community of Practice is prioritizing the development of a consensus-based assessment framework to guide adoption and funding decisions for genetic and genomic biomarkers in cancer care.
The workshop focused on the oncology health human resource challenges we face and fostered collaboration to explore insights and ideas related to the roles of patients and caregivers, new care models, digital innovations, and emerging roles in the system.
